AI News

    DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI

    Google-backed startup eyes the next frontier of drug discovery using advanced generative AI models.

    Read the full story at Bloomberg Technology
    BT

    Bloomberg Technology

    Source

    Bloomberg Technology
    AI Analysis

    Generated insight by OnAirToday AI

    Isomorphic Labs is leveraging Google DeepMind's advanced protein-folding architecture to fundamentally shorten the time required for pharmaceutical drug discovery. By shifting from traditional trial-and-error laboratory methods to predictive computational modeling, this initiative represents a major leap in AI-driven precision medicine.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at Bloomberg Technology →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000